527 related articles for article (PubMed ID: 31210015)
1. Effect of the outer stent position on efficacy after minimally invasive transscleral glaucoma gel stent implantation.
Lenzhofer M; Strohmaier C; Sperl P; Hohensinn M; Hitzl W; Steiner V; Moussa S; Motloch K; Baca B; Krall E; Reitsamer HA
Acta Ophthalmol; 2019 Dec; 97(8):e1105-e1111. PubMed ID: 31210015
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal bleb morphology in anterior segment OCT after minimally invasive transscleral ab interno Glaucoma Gel Microstent implantation.
Lenzhofer M; Strohmaier C; Hohensinn M; Hitzl W; Sperl P; Gerner M; Steiner V; Moussa S; Krall E; Reitsamer HA
Acta Ophthalmol; 2019 Mar; 97(2):e231-e237. PubMed ID: 30160048
[TBL] [Abstract][Full Text] [Related]
3. Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study.
Lenzhofer M; Kersten-Gomez I; Sheybani A; Gulamhusein H; Strohmaier C; Hohensinn M; Burkhard Dick H; Hitzl W; Eisenkopf L; Sedarous F; Ahmed II; Reitsamer HA
Clin Exp Ophthalmol; 2019 Jul; 47(5):581-587. PubMed ID: 30578661
[TBL] [Abstract][Full Text] [Related]
4. Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.
Rauchegger T; Angermann R; Willeit P; Schmid E; Teuchner B
Acta Ophthalmol; 2021 Jun; 99(4):369-375. PubMed ID: 32996702
[TBL] [Abstract][Full Text] [Related]
5. Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors.
Gillmann K; Bravetti GE; Rao HL; Mermoud A; Mansouri K
Acta Ophthalmol; 2021 Jun; 99(4):e531-e539. PubMed ID: 32930515
[TBL] [Abstract][Full Text] [Related]
6. MIGS: therapeutic success of combined Xen Gel Stent implantation with cataract surgery.
Hohberger B; Welge-Lüßen UC; Lämmer R
Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):621-625. PubMed ID: 29335776
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent.
De Gregorio A; Pedrotti E; Russo L; Morselli S
Int Ophthalmol; 2018 Jun; 38(3):1129-1134. PubMed ID: 28555256
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study.
Midha N; Gillmann K; Chaudhary A; Mermoud A; Mansouri K
J Glaucoma; 2020 Jan; 29(1):11-14. PubMed ID: 31702711
[TBL] [Abstract][Full Text] [Related]
9. [XEN
Buffault J; Baudouin C; Labbé A
J Fr Ophtalmol; 2019 Apr; 42(4):391-403. PubMed ID: 30879831
[TBL] [Abstract][Full Text] [Related]
10. Two-Year Outcomes of XEN Gel Stent Surgery in Patients with Open-Angle Glaucoma.
Mansouri K; Bravetti GE; Gillmann K; Rao HL; Ch'ng TW; Mermoud A
Ophthalmol Glaucoma; 2019; 2(5):309-318. PubMed ID: 32672673
[TBL] [Abstract][Full Text] [Related]
11. The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries.
Widder RA; Dietlein TS; Dinslage S; Kühnrich P; Rennings C; Rössler G
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):765-771. PubMed ID: 29356886
[TBL] [Abstract][Full Text] [Related]
12. A Retrospective Analysis of Safety and Efficacy of XEN 45 Microstent Combined Cataract Surgery in Open-Angle Glaucoma over 24 Months.
Subaşı S; Yüksel N; Özer F; Yılmaz Tugan B; Pirhan D
Turk J Ophthalmol; 2021 Jun; 51(3):139-145. PubMed ID: 34187146
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of postoperative management with 5-fluorouracil injections after XEN Gel Stent implantation.
Wałek E; Przeździecka-Dołyk J; Helemejko I; Misiuk-Hojło M
Int Ophthalmol; 2020 Jan; 40(1):235-246. PubMed ID: 31578662
[TBL] [Abstract][Full Text] [Related]
14. Prospective Evaluation of Standalone XEN Gel Implant and Combined Phacoemulsification-XEN Gel Implant Surgery: 1-Year Results.
Mansouri K; Guidotti J; Rao HL; Ouabas A; D'Alessandro E; Roy S; Mermoud A
J Glaucoma; 2018 Feb; 27(2):140-147. PubMed ID: 29271806
[TBL] [Abstract][Full Text] [Related]
15. Double implantation of Xen 45 gel stent in primary open-angle glaucoma: a pilot study.
Grosso A; Ceruti P; Garlasco J; Fröhlich J; Orione M; Gugleta K; Fioretto M; Calzetti G
Int Ophthalmol; 2024 Jun; 44(1):243. PubMed ID: 38904834
[TBL] [Abstract][Full Text] [Related]
16. XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes.
Bravetti GE; Mansouri K; Gillmann K; Rao HL; Mermoud A
Graefes Arch Clin Exp Ophthalmol; 2020 Aug; 258(8):1787-1794. PubMed ID: 32377823
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of XEN-45 gel stent implantation in patients with normal-tension glaucoma.
Nasyrov E; Gassel CJ; Merle DA; Neubauer J; Voykov B
BMC Ophthalmol; 2024 Jun; 24(1):264. PubMed ID: 38902667
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent.
Do A; McGlumphy E; Shukla A; Dangda S; Schuman JS; Boland MV; Yohannan J; Panarelli JF; Craven ER
Ophthalmol Glaucoma; 2021; 4(4):343-349. PubMed ID: 33321200
[TBL] [Abstract][Full Text] [Related]
19. Performance and Safety of a New Ab Interno Gelatin Stent in Refractory Glaucoma at 12 Months.
Grover DS; Flynn WJ; Bashford KP; Lewis RA; Duh YJ; Nangia RS; Niksch B
Am J Ophthalmol; 2017 Nov; 183():25-36. PubMed ID: 28784554
[TBL] [Abstract][Full Text] [Related]
20. XEN
Scheres LMJ; Kujovic-Aleksov S; Ramdas WD; de Crom RMPC; Roelofs LCG; Berendschot TTJM; Webers CAB; Beckers HJM
Acta Ophthalmol; 2021 May; 99(3):e433-e440. PubMed ID: 32909682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
